Korro Bio, Inc.
KRRO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $340 | $75 | $49 | $1,141 |
| - Cash | $56 | $166 | $36 | $83 |
| + Debt | $45 | $33 | $3 | $46 |
| Enterprise Value | $329 | -$58 | $16 | $1,103 |
| Revenue | $2 | $0 | $0 | $14 |
| % Growth | – | – | -100% | – |
| Gross Profit | $2 | $0 | $0 | $10 |
| % Margin | 100% | – | – | 72.7% |
| EBITDA | -$88 | -$81 | -$56 | -$80 |
| % Margin | -3,890.1% | – | – | -569.1% |
| Net Income | -$84 | -$81 | -$58 | -$85 |
| % Margin | -3,680.4% | – | – | -602% |
| EPS Diluted | -9.37 | -53.08 | -227.42 | -4.94 |
| % Growth | 82.3% | 76.7% | -4,503.6% | – |
| Operating Cash Flow | -$60 | -$67 | -$54 | -$32 |
| Capital Expenditures | -$18 | -$8 | -$5 | -$4 |
| Free Cash Flow | -$78 | -$75 | -$59 | -$37 |